Prof Michael Trauner presents: Emerging Role of the Hepatic Thyroid Hormone Pathway in the Pathophysiology of NASH as presented at EASL ‘23: Closing
Melody.education: Educational programs on Nonalcoholic Steatohepatitis (NASH) and Nonalcoholic Fatty Liver Disease (NAFLD)
00:00
Exploring Hepatic Hypothyroidism and its Impact on NASH
This chapter explores the evolving concept of hepatic hypothyroidism and its relevance to Nonalcoholic Steatohepatitis (NASH) and Nonalcoholic Fatty Liver Disease (NAFLD). It emphasizes the rising prevalence of these conditions and discusses innovative liver-targeted treatments currently undergoing clinical trials.
Transcript
Play full episode
